Accolade Financials
| ACCD Stock | USD 3.70 0.01 0.27% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.05 | 2.6012 |
|
|
Investors should never underestimate Accolade's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Accolade's cash flow, debt, and profitability to make informed and accurate decisions about investing in Accolade.
Net Income |
|
Accolade | Select Account or Indicator |
Understanding current and past Accolade Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Accolade's financial statements are interrelated, with each one affecting the others. For example, an increase in Accolade's assets may result in an increase in income on the income statement.
Please note, the presentation of Accolade's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Accolade's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Accolade's management manipulating its earnings.
Accolade Stock Summary
Accolade competes with Privia Health, HealthStream, National Research, Health Catalyst, and Definitive Healthcare. Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania. Accolade operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 2350 people.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US00437E1029 |
| CUSIP | 00437E102 |
| Location | Pennsylvania; U.S.A |
| Business Address | 1201 Third Avenue, |
| Sector | Health Care Technology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.accolade.com |
| Phone | 206 926 8100 |
| Currency | USD - US Dollar |
Accolade Key Financial Ratios
| Return On Equity | -0.19 | ||||
| Profit Margin | (0.18) % | ||||
| Operating Margin | (0.24) % | ||||
| Price To Sales | 0.68 X | ||||
| Revenue | 414.29 M |
Accolade Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Accolade's current stock value. Our valuation model uses many indicators to compare Accolade value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Accolade competition to find correlations between indicators driving Accolade's intrinsic value. More Info.Accolade is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Accolade's Return On Equity is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Accolade by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Accolade Systematic Risk
Accolade's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Accolade volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Accolade correlated with the market. If Beta is less than 0 Accolade generally moves in the opposite direction as compared to the market. If Accolade Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Accolade is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Accolade is generally in the same direction as the market. If Beta > 1 Accolade moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Accolade Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Accolade's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Accolade growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Accolade November 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Accolade help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Accolade. We use our internally-developed statistical techniques to arrive at the intrinsic value of Accolade based on widely used predictive technical indicators. In general, we focus on analyzing Accolade Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Accolade's daily price indicators and compare them against related drivers.
| Information Ratio | (0.10) | |||
| Maximum Drawdown | 14.05 | |||
| Value At Risk | (4.53) | |||
| Potential Upside | 5.87 |
Complementary Tools for Accolade Stock analysis
When running Accolade's price analysis, check to measure Accolade's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accolade is operating at the current time. Most of Accolade's value examination focuses on studying past and present price action to predict the probability of Accolade's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Accolade's price. Additionally, you may evaluate how the addition of Accolade to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |